HK1000094A1 - Pyridinecarboximidamide compound and use thereof - Google Patents
Pyridinecarboximidamide compound and use thereofInfo
- Publication number
- HK1000094A1 HK1000094A1 HK97101521A HK97101521A HK1000094A1 HK 1000094 A1 HK1000094 A1 HK 1000094A1 HK 97101521 A HK97101521 A HK 97101521A HK 97101521 A HK97101521 A HK 97101521A HK 1000094 A1 HK1000094 A1 HK 1000094A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pyridinecarboximidamide
- pyridinecarboximidamide compound
- effect
- compound
- bisalkylsulfonylamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1334292 | 1992-01-28 | ||
JP6622192 | 1992-03-24 | ||
JP32576092 | 1992-12-04 | ||
PCT/JP1993/000103 WO1993015057A1 (en) | 1992-01-28 | 1993-01-28 | Pyridinecarboximidamide compound and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1000094A1 true HK1000094A1 (en) | 1997-11-21 |
Family
ID=27280214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK97101521A HK1000094A1 (en) | 1992-01-28 | 1997-07-08 | Pyridinecarboximidamide compound and use thereof |
Country Status (18)
Country | Link |
---|---|
US (1) | US5508293A (no) |
EP (1) | EP0634400B1 (no) |
JP (1) | JP2648395B2 (no) |
KR (1) | KR100249755B1 (no) |
CN (1) | CN1043760C (no) |
AT (1) | ATE151073T1 (no) |
AU (1) | AU674839B2 (no) |
CA (1) | CA2129013C (no) |
DE (1) | DE69309454T2 (no) |
DK (1) | DK0634400T3 (no) |
ES (1) | ES2100522T3 (no) |
FI (1) | FI105399B (no) |
HK (1) | HK1000094A1 (no) |
HU (1) | HU218487B (no) |
MX (1) | MX9300433A (no) |
NO (1) | NO302070B1 (no) |
TW (1) | TW232009B (no) |
WO (1) | WO1993015057A1 (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6075024A (en) | 1991-11-27 | 2000-06-13 | Sepracor Inc. | Methods for treating infection using optically pure (S)-lomefloxacin |
WO1997000239A1 (fr) * | 1995-06-14 | 1997-01-03 | Sankyo Company, Limited | Medicament contre l'angine contenant un derive nitroxy comme ingredient actif |
AU5880198A (en) * | 1997-02-14 | 1998-09-08 | Kirin Beer Kabushiki Kaisha | Drugs for relieving peripheral circulation disorder |
US7393652B2 (en) * | 2000-05-10 | 2008-07-01 | The Trustees Of Columbia University In The City Of New York | Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2) |
US20040229781A1 (en) * | 2000-05-10 | 2004-11-18 | Marks Andrew Robert | Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias |
US7312044B2 (en) | 2003-03-07 | 2007-12-25 | The Trustees Of Columbia University In The City Of New York | Type 1 ryanodine receptor-based methods |
US20060293266A1 (en) * | 2000-05-10 | 2006-12-28 | The Trustees Of Columbia | Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure |
US8022058B2 (en) | 2000-05-10 | 2011-09-20 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
US6489125B1 (en) * | 2000-05-10 | 2002-12-03 | The Trustees Of Columbia University In The City Of New York | Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor |
US7718644B2 (en) * | 2004-01-22 | 2010-05-18 | The Trustees Of Columbia University In The City Of New York | Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof |
US7879840B2 (en) * | 2005-08-25 | 2011-02-01 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
US20040048780A1 (en) * | 2000-05-10 | 2004-03-11 | The Trustees Of Columbia University In The City Of New York | Method for treating and preventing cardiac arrhythmia |
JP2003321329A (ja) * | 2002-04-25 | 2003-11-11 | Kirin Brewery Co Ltd | 育毛剤 |
US7544678B2 (en) * | 2002-11-05 | 2009-06-09 | The Trustees Of Columbia University In The City Of New York | Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) |
US8710045B2 (en) * | 2004-01-22 | 2014-04-29 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
US7704990B2 (en) * | 2005-08-25 | 2010-04-27 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
TW200908984A (en) | 2007-08-07 | 2009-03-01 | Piramal Life Sciences Ltd | Pyridyl derivatives, their preparation and use |
EP3088390A1 (en) | 2015-04-30 | 2016-11-02 | Bayer CropScience AG | Catalytic hydrogenation of substituted cyanopyridines |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI95244C (fi) * | 1988-12-27 | 1996-01-10 | Kirin Brewery | Analogiamenetelmä valmistaa lääkeaineina käyttökelpoisia uusia karboksimidiamidijohdannaisia tai niiden farmaseuttisesti sopivia happoadditiosuoloja |
JPH0662567B2 (ja) * | 1988-12-27 | 1994-08-17 | 麒麟麦酒株式会社 | ピリジンカルボキシイミダミド誘導体、その製造中間体、製造法および用途 |
JP2846070B2 (ja) * | 1989-11-29 | 1999-01-13 | 麒麟麦酒株式会社 | カルボキシイミダミド誘導体 |
-
1993
- 1993-01-27 MX MX9300433A patent/MX9300433A/es not_active IP Right Cessation
- 1993-01-28 AU AU33677/93A patent/AU674839B2/en not_active Ceased
- 1993-01-28 US US08/256,625 patent/US5508293A/en not_active Expired - Lifetime
- 1993-01-28 TW TW082100471A patent/TW232009B/zh active
- 1993-01-28 DK DK93902543.3T patent/DK0634400T3/da active
- 1993-01-28 CA CA002129013A patent/CA2129013C/en not_active Expired - Fee Related
- 1993-01-28 JP JP5513093A patent/JP2648395B2/ja not_active Expired - Fee Related
- 1993-01-28 WO PCT/JP1993/000103 patent/WO1993015057A1/ja active IP Right Grant
- 1993-01-28 AT AT93902543T patent/ATE151073T1/de not_active IP Right Cessation
- 1993-01-28 EP EP93902543A patent/EP0634400B1/en not_active Expired - Lifetime
- 1993-01-28 CN CN93102390A patent/CN1043760C/zh not_active Expired - Fee Related
- 1993-01-28 DE DE69309454T patent/DE69309454T2/de not_active Expired - Fee Related
- 1993-01-28 KR KR1019940702577A patent/KR100249755B1/ko not_active IP Right Cessation
- 1993-01-28 HU HU9402218A patent/HU218487B/hu not_active IP Right Cessation
- 1993-01-28 ES ES93902543T patent/ES2100522T3/es not_active Expired - Lifetime
-
1994
- 1994-07-22 NO NO942740A patent/NO302070B1/no unknown
- 1994-07-26 FI FI943508A patent/FI105399B/fi active
-
1997
- 1997-07-08 HK HK97101521A patent/HK1000094A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR950700255A (ko) | 1995-01-16 |
HUT70506A (en) | 1995-10-30 |
EP0634400B1 (en) | 1997-04-02 |
ES2100522T3 (es) | 1997-06-16 |
AU674839B2 (en) | 1997-01-16 |
TW232009B (no) | 1994-10-11 |
DK0634400T3 (da) | 1997-04-28 |
CA2129013C (en) | 2001-08-14 |
CN1077949A (zh) | 1993-11-03 |
AU3367793A (en) | 1993-09-01 |
JP2648395B2 (ja) | 1997-08-27 |
FI105399B (fi) | 2000-08-15 |
DE69309454T2 (de) | 1997-08-14 |
EP0634400A1 (en) | 1995-01-18 |
CN1043760C (zh) | 1999-06-23 |
EP0634400A4 (en) | 1995-06-14 |
NO942740D0 (no) | 1994-07-22 |
US5508293A (en) | 1996-04-16 |
WO1993015057A1 (en) | 1993-08-05 |
NO302070B1 (no) | 1998-01-19 |
HU218487B (hu) | 2000-09-28 |
KR100249755B1 (ko) | 2000-04-01 |
NO942740L (no) | 1994-09-27 |
CA2129013A1 (en) | 1993-07-29 |
FI943508A0 (fi) | 1994-07-26 |
MX9300433A (es) | 1994-07-29 |
FI943508A (fi) | 1994-09-22 |
ATE151073T1 (de) | 1997-04-15 |
DE69309454D1 (de) | 1997-05-07 |
HU9402218D0 (en) | 1994-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW232009B (no) | ||
IL148516A (en) | Retroviral protease inhibiting compound | |
EP0906907A4 (no) | ||
IE832713L (en) | Indole derivatives. | |
TW223637B (no) | ||
EP0480061A4 (en) | Hepatic disorder inhibitor | |
KR900701717A (ko) | 2--1,3-시클로헥산디온제초제 화합물과 이를 이용한 조성물 및 식물억제방법 | |
ES8404976A1 (es) | Procedimiento para preparar nuevos derivados de encefalina. | |
SG52733A1 (en) | Methotrexate derivative | |
MX9804861A (es) | Mezclas fungicidas. | |
EP0627425A4 (no) | ||
ES8205219A1 (es) | Un metodo para producir un compuesto de hidrouracilo | |
GR3021821T3 (en) | 5-amino-2-phenoxysulfonanilide compound. | |
GR3001784T3 (en) | Amino compounds and fungicides containing them | |
DK551487A (da) | 1-hydroxyalkylxanthiner samt farmaceutiske praeparater med indhold af saadanne forbindelser | |
NO954410L (no) | Fremgangsmåte og fremstilling av NG-monoalkyl-L-arginin og beslektede forbindelser | |
ES2099004A1 (es) | Nuevos antifungicos activos por via oral. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20090128 |